Clinical guidelines for testing for heritable thrombophilia

被引:343
作者
Baglin, Trevor [1 ]
Gray, Elaine [2 ]
Greaves, Mike [3 ]
Hunt, Beverley J. [4 ]
Keeling, David [5 ]
Machin, Sam [6 ]
Mackie, Ian [6 ]
Makris, Mike [7 ]
Nokes, Tim [8 ]
Perry, David [1 ]
Tait, R. C. [9 ]
Walker, Isobel [9 ]
Watson, Henry [10 ]
机构
[1] Addenbrookes Hosp, Cambridge, England
[2] NIBSC, S Mimms, Herts, England
[3] Univ Aberdeen, Aberdeen, Scotland
[4] Guys & St Thomas, London, England
[5] Churchill Hosp, Oxford OX3 7LJ, England
[6] Univ Coll Hosp, London, England
[7] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
[8] Derriford Hosp, Plymouth PL6 8DH, Devon, England
[9] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[10] Aberdeen Royal Infirm, Aberdeen, Scotland
关键词
anticoagulation; thrombophilia; venous thrombosis; FACTOR-V-LEIDEN; RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; HORMONE REPLACEMENT THERAPY; PROTEIN-S DEFICIENCY; RISK-FACTORS; INHERITED THROMBOPHILIA; ASYMPTOMATIC CARRIERS; ORAL-CONTRACEPTIVES; PROTHROMBIN GENE;
D O I
10.1111/j.1365-2141.2009.08022.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:209 / 220
页数:12
相关论文
共 69 条
[1]   INCREASED RISK OF VENOUS THROMBOSIS IN CARRIERS OF HEREDITARY PROTEIN-C DEFICIENCY DEFECT [J].
ALLAART, CF ;
POORT, SR ;
ROSENDAAL, FR ;
REITSMA, PH ;
BERTINA, RM ;
BRIET, E .
LANCET, 1993, 341 (8838) :134-138
[2]   The JAK2V617F mutation and thrombosis [J].
Austin, S. K. ;
Lambert, J. R. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (03) :307-320
[3]   Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study [J].
Baglin, T ;
Luddington, R ;
Brown, K ;
Baglin, C .
LANCET, 2003, 362 (9383) :523-526
[4]   Communicating benefit and risk [J].
Baglin, Trevor .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (01) :31-33
[5]   Social aspects of genetic testing for factor V leiden mutation in healthy individuals and their importance for daily practice [J].
Bank, I ;
Scavenius, MPRB ;
Büller, HR ;
Middeldorp, S .
THROMBOSIS RESEARCH, 2004, 113 (01) :7-12
[6]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[7]   Safety of withholding heparin in pregnant women with a history of venous thromboembolism. [J].
Brill-Edwards, P ;
Ginsberg, JS ;
Gent, M ;
Hirsh, J ;
Burrows, R ;
Kearon, C ;
Geerts, W ;
Kovacs, M ;
Weitz, JI ;
Robinson, KS ;
Whittom, R ;
Couture, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1439-1444
[8]   Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis [J].
Canonico, Marianne ;
Plu-Bureau, Genevieve ;
Lowe, Gordon D. O. ;
Scarabin, Pierre-Yves .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7655) :1227-+
[9]   The "ART" of thromboembolism: A review of assisted reproductive technology and thromboembolic complications [J].
Chan, W. S. ;
Dixon, M. E. .
THROMBOSIS RESEARCH, 2008, 121 (06) :713-726
[10]   Thrombophilia, clinical factors, and recurrent venous thrombotic events [J].
Christiansen, SC ;
Cannegieter, SC ;
Koster, T ;
Vandenbroucke, JP ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (19) :2352-2361